Multiple Sclerosis Trial, Recruiting NCT06968039 Sponsor: Xuanwu Hospital, Beijing Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06968039
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with Neuromyelitis Optica Spectrum Disorders (NMOSD), Multiple Sclerosis (MS), or other inflammatory diseases affecting the brain and spinal cord that meet recognised diagnostic standards
  • People who score below 55 on a cognitive processing speed test (called the SDMT), or who feel their thinking or memory has gotten worse
  • People aged between 18 and 65 years old, any gender
  • People who have not had a relapse or changed their medications in the past month
  • People whose disability level scores at 6 or below on a standard neurological disability scale (called the EDSS)
  • People who are right-handed, are native Chinese speakers, and have enough education to understand the test instructions
  • People who are willing to take part and have signed a consent form

Who may not be able to join:

  • People who have had a relapse in the past month
  • People who have changed their medications in the past month, or have recently had electroconvulsive therapy, transcranial magnetic stimulation, or similar brain stimulation treatments
  • People who are currently taking part in, or have taken part in, another clinical trial within the past month
  • People who have a cochlear hearing implant, a heart pacemaker, or an implanted brain stimulation device
  • People who have broken or damaged skin at the sites where electrodes would be placed, or who have an allergy to electrode gel or adhesive materials
  • People with a history of epilepsy, fluid on the brain (hydrocephalus), brain or spinal cord tumours, brain injury, or infections of the brain or spinal cord
  • People who are pregnant, breastfeeding, or planning to become pregnant in the near future
  • People who score 3 or higher on the suicide-related question of a standard depression assessment (HDRS-17), or who have a serious mental illness
  • People who have another serious or unstable physical health condition
  • People who are unlikely to be able to cooperate with treatment sessions, follow-up appointments, or the collection of medical, brain scan, or EEG data
  • People whom the research team considers unsuitable for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 010+83198277

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
31 December 2024
Est. completion
1 July 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Working Memory Training-Related Scores; SDMT (Symbol Digit Modalities Test)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov